Gossamer Bio Inc. (GOSS) Tops Q2 EPS by 4c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance